madman
Super Moderator
In this episode, Dr. Kevin Chu and Justin Dubin discuss the recent updates to testosterone therapy labels, debunk myths about prostate cancer risks, and explore the future of testosterone treatment and regulation. They emphasize the importance of evidence-based practice and evolving medical guidelines.
Chapters
00:00 Introduction to 2026 Testosterone Label Changes
02:30 Impact of Label Changes on Provider Practices
06:55 Reevaluating Prostate Cancer Risks with Testosterone
12:02 Monitoring and Counseling Patients on TRT
20:03 Benign Prostatic Hyperplasia and Testosterone
29:01 Discussion on Descheduling Testosterone
33:49 Telemedicine and Future of Hormone Therapy
38:50 Summary and Final Thoughts